Abstract
The objective of the study : to define the informative value of q SOFA score in the prediction of sepsis outcomes in the patients admitted to the intensive care wards of medical units in the Russian Federation. Subjects and methods. The mult i-c enter, prospective, and observational trial was conducted. The following data were analyzed in the patients admitted to intensive care wards: number of q SOFA and SOFA scores, the presence of SIRS criteria, levels of lactate, and the outcome of the admission to the intensive care wards. The informative value of different scores and lactate level was analyzed using RO C -a nalysis. Results. The following areas under RO C -c urves were defined for prediction of a lethal outcome in the patients with sepsis: q SOFA – 0.644 (95% CI 0.593–0.693); SOFA – 0.731 (95% CI 0.683–0.776); SIRS – 0.508 (95% CI 0.456–0.560); [q SOFA + lactate ≥ 4 mmo l/L ] – 0.713 (95% CI 0.646–0.774). Conclusion. To predict a lethal outcome in the patients with sepsis admitted to intensive care wards, q SOFA surpasses SIRS criteria, but it is not as good as SOFA score. The informative value of the prediction model [q SOFA +lactate ≥ 4 mmo l/L ] surpasses q SOFA score in the prediction of the outcome in sepsis patients, and it is as good as SOFA score.
Highlights
ИСПОЛЬЗОВАНИЕ ШКАЛЫ qSOFA В ПРОГНОЗЕ ИСХОДА У ПАЦИЕНТОВ С СЕПСИСОМ В отделения реанимации и интенсивной терапии (ОРИТ)
The following areas under ROC-curves were defined for prediction of a lethal outcome in the patients with sepsis: qSOFA – 0.644; SOFA – 0.731; SIRS – 0.508; [qSOFA + lactate ≥ 4 mmol/L] – 0.713
To predict a lethal outcome in the patients with sepsis admitted to intensive care wards, qSOFA surpasses SIRS criteria, but it is not as good as SOFA score
Summary
The following areas under ROC-curves were defined for prediction of a lethal outcome in the patients with sepsis: qSOFA – 0.644 (95% CI 0.593–0.693); SOFA – 0.731 (95% CI 0.683–0.776); SIRS – 0.508 (95% CI 0.456–0.560); [qSOFA + lactate ≥ 4 mmol/L] – 0.713 (95% CI 0.646–0.774)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.